Fabry App: the value of a portable technology in recording day-to-day patient monitored information in patients with Fabry disease

Simona D’Amore,Mark Mckie,Andrew Fahey,David Bleloch,Giuseppina Grillo,Michael Hughes,Uma Ramaswami
DOI: https://doi.org/10.1186/s13023-023-02999-6
2024-01-13
Orphanet Journal of Rare Diseases
Abstract:Fabry disease is a rare inherited disorder resulting from deficient α-galactosidase A enzyme activity. Common disease manifestations are sweating abnormalities, neuropathic pain, gastrointestinal symptoms and fatigue. Challenges are faced by health care professionals in evaluating symptom burden in the current clinical setting, and the demand for alternative methods for monitoring disease-specific symptoms has seen an acceleration in recent years. Smartphone technologies offer the potential for continuity of care and surveillance. As a part of a quality improvement project, a disease specific app was developed in collaboration with a software company (Health Touch Ltd) and made available for patient use in May 2018. The Fabry mobile app records five categories: pain, gastrointestinal symptoms, sweating, activity levels, medications. Fabry disease patients with gastrointestinal and pain symptoms attending the Lysosomal Storage Disorders Unit of the Royal Free London NHS Foundation Trust were reviewed to assess eligibility and invited to download the app for recording their symptoms (activity, sweating, pain and gastrointestinal) and medications. Patient-generated data were transmitted to a secure website for clinicians to review.
genetics & heredity,medicine, research & experimental
What problem does this paper attempt to address?